Insulet Corporation (PODD)Healthcare | Medical Devices | Acton, United States | NasdaqGS
203.73 USD
+2.26
(1.122%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 204.30 +0.57 (0.280%) ⇧ (April 17, 2026, 7:13 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★★★☆ | Dividends: ★★☆☆☆ |
Hot Take | April 18, 2026, 10:19 p.m. EDT
Despite a 'Strong Buy' analyst consensus and solid long-term secular growth, the immediate technical picture is broken. Stock has fallen nearly 15% over the past two weeks, approaching multi-year lows, while options market makers are heavily hedged against catastrophe levels below $250. The massive short interest rise and pending lawsuit investigation suggest a 'sell the news' event regarding the device defect concealment allegations is likely to suppress the price further before the longer-term revenue growth and cash conversion can drive a higher low. This is a long-term compounder entry, not a short-term momentum play. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.062379 |
| AutoTheta | 0.103295 |
| MSTL | 0.149783 |
| AutoETS | 0.151860 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 6.38 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.132 |
| Excess Kurtosis | -1.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 66.176 |
| Revenue per Share | 38.496 |
| Market Cap | 14,341,745,664 |
| Trailing P/E | 58.54 |
| Forward P/E | 25.21 |
| Beta | 1.47 |
| Profit Margins | 9.12% |
| Website | https://www.insulet.com |
As of April 18, 2026, 10:19 p.m. EDT: Options flow indicates a strong bearish bias in the short term. In the April 17 expiry, put activity is dominated by deep ITM strikes (230, 240) with massive volume spikes and a higher IV premium compared to calls, suggesting a 'belayer' strategy by holders to cap downside at 240. In contrast, call activity is anomalous with significant OTM positioning above par (strikes 260, 270) and poor volume/flow relative to price, indicating sentiment is saturated with downside protection rather than immediate upside bets. The April 17 ITM put positioning is 4x the volume of OTM puts, a clear contrarian signal for short-term weakness.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.1460368 |
| Address1 | 100 Nagog Park |
| All Time High | 354.88 |
| All Time Low | 2.57 |
| Ask | 204.44 |
| Ask Size | 4 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 820,370 |
| Average Daily Volume3 Month | 1,048,622 |
| Average Volume | 1,048,622 |
| Average Volume10Days | 820,370 |
| Beta | 1.47 |
| Bid | 201.66 |
| Bid Size | 4 |
| Board Risk | 5 |
| Book Value | 21.526 |
| City | Acton |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 203.73 |
| Current Ratio | 2.814 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 205.95 |
| Day Low | 201.89 |
| Debt To Equity | 66.176 |
| Display Name | Insulet |
| Earnings Call Timestamp End | 1,778,068,800 |
| Earnings Call Timestamp Start | 1,778,068,800 |
| Earnings Growth | 0.039 |
| Earnings Quarterly Growth | 0.009 |
| Earnings Timestamp | 1,778,070,600 |
| Earnings Timestamp End | 1,778,070,600 |
| Earnings Timestamp Start | 1,778,070,600 |
| Ebitda | 564,200,000 |
| Ebitda Margins | 0.20833999 |
| Enterprise To Ebitda | 25.928 |
| Enterprise To Revenue | 5.402 |
| Enterprise Value | 14,628,345,856 |
| Eps Current Year | 6.34404 |
| Eps Forward | 8.08034 |
| Eps Trailing Twelve Months | 3.48 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 228.266 |
| Fifty Day Average Change | -24.53601 |
| Fifty Day Average Change Percent | -0.10748868 |
| Fifty Two Week Change Percent | -14.603681 |
| Fifty Two Week High | 354.88 |
| Fifty Two Week High Change | -151.15001 |
| Fifty Two Week High Change Percent | -0.42591864 |
| Fifty Two Week Low | 194.61 |
| Fifty Two Week Low Change | 9.119995 |
| Fifty Two Week Low Change Percent | 0.04686293 |
| Fifty Two Week Range | 194.61 - 354.88 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,179,235,800,000 |
| Float Shares | 70,100,185 |
| Forward Eps | 8.08034 |
| Forward P E | 25.213047 |
| Free Cashflow | 154,900,000 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 5,400 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.71633005 |
| Gross Profits | 1,939,900,032 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0031299999 |
| Held Percent Institutions | 1.05443 |
| Implied Shares Outstanding | 70,395,849 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://investor.insulet.com/index.cfm |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. |
| Long Name | Insulet Corporation |
| Market | us_market |
| Market Cap | 14,341,745,664 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_618908 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 247,100,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 14,104,170,081 |
| Number Of Analyst Opinions | 23 |
| Open | 204.14 |
| Operating Cashflow | 569,299,968 |
| Operating Margins | 0.18665001 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.13 |
| Phone | 978 600 7000 |
| Post Market Change | 0.5700073 |
| Post Market Change Percent | 0.27978566 |
| Post Market Price | 204.3 |
| Post Market Time | 1,776,467,592 |
| Previous Close | 201.47 |
| Price Eps Current Year | 32.113605 |
| Price Hint | 2 |
| Price To Book | 9.464369 |
| Price To Sales Trailing12 Months | 5.29587 |
| Profit Margins | 0.091239996 |
| Quick Ratio | 1.813 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 2.25999 |
| Regular Market Change Percent | 1.12175 |
| Regular Market Day High | 205.95 |
| Regular Market Day Low | 201.89 |
| Regular Market Day Range | 201.89 - 205.95 |
| Regular Market Open | 204.14 |
| Regular Market Previous Close | 201.47 |
| Regular Market Price | 203.73 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 839,021 |
| Return On Assets | 0.09434 |
| Return On Equity | 0.18124 |
| Revenue Growth | 0.312 |
| Revenue Per Share | 38.496 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 69,263,714 |
| Shares Percent Shares Out | 0.044 |
| Shares Short | 3,049,595 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,817,783 |
| Short Name | Insulet Corporation |
| Short Percent Of Float | 0.0497 |
| Short Ratio | 3.13 |
| Source Interval | 15 |
| State | MA |
| Symbol | PODD |
| Target High Price | 435.0 |
| Target Low Price | 230.0 |
| Target Mean Price | 333.30435 |
| Target Median Price | 340.0 |
| Total Cash | 716,099,968 |
| Total Cash Per Share | 10.172 |
| Total Debt | 1,002,700,032 |
| Total Revenue | 2,708,100,096 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 3.48 |
| Trailing P E | 58.543102 |
| Trailing Peg Ratio | 1.1282 |
| Triggerable | 1 |
| Two Hundred Day Average | 287.58206 |
| Two Hundred Day Average Change | -83.852066 |
| Two Hundred Day Average Change Percent | -0.29157615 |
| Type Disp | Equity |
| Volume | 839,021 |
| Website | https://www.insulet.com |
| Zip | 1,720 |